Study at a glance
What was studied?
Researchers studied early placental cells, the mother’s uterine cells during pregnancy and blood samples from pregnant women. They asked how vitamin D compounds relate to cell movement, immune signals and pregnancy outcomes.
What did the studies find?
Some cell movements and immune signals changed. Other measurements, including an immune-cell killing test, showed no clear change. In women at higher risk, later vitamin D blood levels were linked with pregnancy complications. This observational study did not show that supplements prevented complications.
What does this mean?
The studies show particular local responses. They do not prove better fetal development or successful immune tolerance. Immune tolerance means avoiding inappropriate immune attack while keeping useful defence.
What are the limits?
Many experiments were small and used cells outside the body. Some experiments supplied the active vitamin D hormone directly, rather than an ordinary vitamin D3 supplement. One relevant report was available only as an abstract, so its full methods and results could not be assessed. The evidence does not establish a personal pregnancy dose.
Read the full article below ↓Vitamin D compounds changed some placental and maternal uterine cells in laboratory studies. This suggests local biological activity, but does not show that taking more vitamin D improves fetal development or improves immune tolerance during pregnancy. Immune tolerance means avoiding inappropriate immune attack while retaining useful defence. Cell experiments, tissue comparisons and blood measurements answer different questions. The detailed assessment is Placental Vitamin D Signalling, Fetal Development and Immune Tolerance: Full Evidence Review.
What was studied?
The review compares five investigations. Some studied trophoblasts, cells that help establish the placenta. Others studied decidua, the mother’s uterine tissue during pregnancy. These tissues meet, but they are not the same. A response in one cannot automatically be assumed to occur in the other.
The experiments also used different vitamin D compounds. Calcitriol is the active hormone. Its precursor, 25-hydroxyvitamin D, needs further conversion before it acts through the same hormone pathway. Neither should be confused with an ordinary vitamin D3 supplement. Laboratory exposures do not establish a personal pregnancy dose. The conversion background is Vitamin D Metabolism at the Cellular Level.
What did the cell experiments find?
Chan and colleagues found that some exposures increased movement of early human placental cells through a laboratory barrier. More exposure did not consistently produce a greater response. The experiment did not measure successful implantation or healthier fetal development.
Westwood and colleagues studied a different signal that reduced cell movement in their models. Calcitriol reduced that effect in cell lines. The result was not a demonstration of improved placental function in an intact pregnancy. Cell lines can differ from normal tissue.
Evans and colleagues studied maternal uterine cells. Vitamin D compounds reduced several cytokines, which are signalling molecules used by cells to communicate. However, a test of immune-cell killing showed no clear change. An enzyme associated with immune regulation did not increase its gene activity after treatment. A gene involved in producing an antimicrobial peptide did respond, but the study did not demonstrate protection against infection. For the signalling background, see Vitamin D and Cytokine Balance.
What did the human comparisons show?
Li and colleagues compared tissue from 30 women with recurrent pregnancy loss and 30 women having elective terminations. Some vitamin D and inflammatory measurements differed. The cases were sampled after pregnancy failure. The differences could therefore be consequences of loss rather than causes. The study did not show that supplementation prevents miscarriage.
Raia-Barjat and colleagues followed blood measurements in 182 women at higher risk of pregnancy complications. An association with placenta-related complications was more apparent late in pregnancy. Earlier measurements did not clearly distinguish groups. This was an observational study, not a trial showing that supplements prevented the complications.
An important report was not available in full
Barrera and colleagues reported reduced interleukin-10 after calcitriol exposure in cultured placental cells. This signalling molecule is often described as anti-inflammatory, meaning that it can limit inflammation. The reported decrease challenges the simple idea that vitamin D always increases anti-inflammatory signals.
Only the abstract was accessible for this review. The full methods and results could not be assessed. The report is included with that limit, rather than treated as fully checked evidence or as proof of harm in pregnancy.
What does this mean?
The evidence supports particular local responses. It does not prove improved fetal growth, organ development or later child health. Nor do changes in signalling molecules prove successful immune tolerance, which involves avoiding inappropriate immune attack while retaining useful defence. The wider concept is explained in Vitamin D and Immune Tolerance.
Several experiments were small. Tissue types, pregnancy stages and vitamin D compounds differed. A blood association is not the same as an intervention result. The research therefore does not establish an individual supplement plan or blood-test target. It supports further investigation while leaving the clinical benefits uncertain.
Sources
Related reading
An Optimized Method to Generate Human Active Osteoclasts From Peripheral Blood Monocytes
The aim of this study was to develop a procedure yielding active and mature OCs from fresh human PBMCs.
Original paper ↗Read more →Cord Blood 25-hydroxyvitamin D and Fetal Growth in the China-Anhui Birth Cohort Study
Compared with neonates in the lowest decile of cord blood 25(OH)D levels, neonates in four deciles (the fourth, fifth, sixth and seventh deciles) had significantly increased birth weight and decreased risk of SGA.
Original paper ↗Read more →Women with recurrent spontaneous abortion have decreased 25(OH) vitamin D and VDR at the fetal-maternal interface
The objective of this study was to investigate 25-hydroxyvitamin D [25(OH) D] concentration and vitamin D receptor (VDR) expression in the decidual tissues of RSA patients.
Original paper ↗Read more →Vitamin D attenuates sphingosine-1-phosphate (S1P)-mediated inhibition of extravillous trophoblast migration
Failure of trophoblast invasion and remodelling of maternal blood vessels leads to the pregnancy complication pre-eclampsia (PE).
Original paper ↗Read more →Vitamin D deficiency during late pregnancy mediates placenta-associated complications
Aim of the study was to evaluate the relationship between vitamin D status and the occurrence of placenta-mediated complications (PMCs) in a population at high risk.
Original paper ↗Read more →Placental Vitamin D Signalling, Fetal Development and Immune Tolerance: Full Evidence Review
Human placental and decidual studies assess vitamin D signalling, fetal development and immune tolerance, with clinical and source-access limits.
Read more →Effect of Vitamin D Supplementation on the Cerebral Placental Ratio in Pregnancy Complicated with Early Fetal Growth Restriction
The aim is to assess the relationship between CPR and vitamin D supplementation in fetuses with early FGR.
Original paper ↗Read more →Association between maternal vitamin D, calcium, and inflammatory cytokines in Iraqi pregnant women with placental calcification
The pro-inflammatory marker TNF-α was significantly increased in G3 compared to the control group (p = 0.016).
Original paper ↗Read more →Multi-site metabolomics reveals one-carbon and placental steroid disruption in maternal pre-pregnancy obesity linked to adverse pregnancy outcomes
This study characterized metabolomic profiles of maternal adipose tissue, placenta, and cord blood in pre-pregnancy obesity and explored links to adverse pregnancy outcomes (APOs).
Original paper ↗Read more →Vitamin D Receptor Gene Ablation in the Conceptus Has Limited Effects on Placental Morphology, Function and Pregnancy Outcome
Vitamin D deficiency has been implicated in the pathogenesis of several pregnancy complications attributed to impaired or abnormal placental function, but there are few clues indicating the mechanistic role of vitamin D in their pathogenesis.
Original paper ↗Read more →Early-pregnancy transcriptome signatures of preeclampsia: from peripheral blood to placenta
Several studies have linked maternal asthma, excess BMI, and low vitamin D status with increased risk of Preeclampsia (PE) development.
Original paper ↗Read more →Evaluation of 1,25(OH)2D3 Effects on FOXP3, ROR-γt, GITR, and CTLA-4 Gene Expression in PBMCs of Vitamin D-Deficient Women with Unexplained Recurrent Pregnancy Loss
This study aimed at evaluating the effect of 1,25VitD3 on specific transcription factor and markers of Tregs and Th17 cells in PBMCs of women with URPL as a case group and PBMCs of healthy women as a control group.
Original paper ↗Read more →Placental Vitamin D Metabolism and Transport: Full Evidence Review
Human placental experiments and pregnancy-trial samples clarify vitamin D uptake, local metabolism and limits of fetal-health interpretation.
Read more →COVID-19 during Gestation: Maternal Implications of Evoked Oxidative Stress and Iron Metabolism Impairment
The purpose of this study was to investigate, for the first time, the effects of COVID-19 infection during pregnancy with regard to the oxidative/antioxidant status in mothers’ serum and placenta, together with placental iron metabolism.
Original paper ↗Read more →Immunomodulatory Effects of Vitamin D in Pregnancy and Beyond
The effects of vitamin D on the production and action of several cytokines has been intensively investigated in recent years.
Original paper ↗Read more →The Association of Prenatal Vitamin D Status With Pregnancy and Neonatal Outcomes
Vitamin D inadequacy is globally prevalent among pregnant women; however, its impact on pregnancy remains inconclusive.
Original paper ↗Read more →Vitamin D Receptor: Interplay in COVID-19-Negative,: Infected, and: Vaccinated Women during Pregnancy
We aim to underline a possible mechanism that would explain negative fetal outcomes in COVID-19-positive mothers by examining the relationship between altered placental structure and function and throphoblast cells‘ vitamin D receptor levels.
Original paper ↗Read more →Maternal Vitamin D Status at Week 30 of Gestation and Offspring Cardio-Metabolic Health at 20 Years: A Prospective Cohort Study over Two Decades
The aim of the present study was to investigate the association between maternal serum concentration of vitamin D (25(OH)D) in week 30 of gestation and offspring cardio-metabolic risk factors at 20 years.
Original paper ↗Read more →Untargeted analysis of first trimester serum to reveal biomarkers of pregnancy complications: a case-control discovery phase study
Understanding of causal biology and predictive biomarkers are lacking for hypertensive disorders of pregnancy (HDP) and preterm birth (PTB).
Original paper ↗Read more →Vitamin D and Pregnancy Physiology
Explore how vitamin D interacts with pregnancy physiology, including hormonal regulation, immune adaptation, mineral balance, and developmental signalling across gestation.
Read more →Cohort profile: the Genetics of Glucose regulation in Gestation and Growth (Gen3G): a prospective prebirth cohort of mother-child pairs in Sherbrooke, Canada, 3-year and 5-year follow-up visits
We also investigated molecular mechanisms involved in the fetal programming of these later health outcomes.
Original paper ↗Read more →Original sources
Vitamin D promotes human extravillous trophoblast invasion in vitro
Published in Chan SY et al. Placenta (2015).
Publication details
Vitamin D promotes human extravillous trophoblast invasion in vitro. Chan SY et al. Placenta. 2015;36(4):403 to 409. DOI: 10.1016/j.placenta.2014.12.021.
Vitamin D attenuates sphingosine-1-phosphate (S1P)-mediated inhibition of extravillous trophoblast migration
Failure of trophoblast invasion and remodelling of maternal blood vessels leads to the pregnancy complication pre-eclampsia (PE).
Publication details
Vitamin D attenuates sphingosine-1-phosphate (S1P)-mediated inhibition of extravillous trophoblast migration. Westwood M et al. Placenta. 2017;60:1 to 8. DOI: 10.1016/j.placenta.2017.09.009.
Effects of 25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 on Cytokine Production by Human Decidual Cells
Published in Evans KN et al. Biology of Reproduction (2006).
Publication details
Effects of 25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 on Cytokine Production by Human Decidual Cells. Evans KN et al. Biology of Reproduction. 2006;75(6):816 to 822. DOI: 10.1095/biolreprod.106.054056.
Women with recurrent spontaneous abortion have decreased 25(OH) vitamin D and VDR at the fetal-maternal interface
The objective of this study was to investigate 25-hydroxyvitamin D [25(OH) D] concentration and vitamin D receptor (VDR) expression in the decidual tissues of RSA patients.
Publication details
Women with recurrent spontaneous abortion have decreased 25(OH) vitamin D and VDR at the fetal-maternal interface. Li N et al. Brazilian Journal of Medical and Biological Research. 2017;50(11):e6527. DOI: 10.1590/1414-431X20176527.
Vitamin D deficiency during late pregnancy mediates placenta-associated complications
Aim of the study was to evaluate the relationship between vitamin D status and the occurrence of placenta-mediated complications (PMCs) in a population at high risk.
Publication details
Vitamin D deficiency during late pregnancy mediates placenta-associated complications. Raia-Barjat T et al. Scientific Reports. 2021;11:20708. Observational AngioPred analysis; causal wording in the title is not adopted as this review’s conclusion. DOI: 10.1038/s41598-021-00250-5.
Calcitriol inhibits interleukin-10 expression in cultured human trophoblasts under normal and inflammatory conditions
Published in Barrera D et al. Cytokine (2012).
Publication details
Calcitriol inhibits interleukin-10 expression in cultured human trophoblasts under normal and inflammatory conditions. Barrera D et al. Cytokine. 2012;57(3):316 to 321. ABSTRACT ONLY: full principal unavailable; not counted as fully assessed evidence. DOI: 10.1016/j.cyto.2011.11.020.